Astrana Health, Inc. (NASDAQ:ASTH) Short Interest Update

Astrana Health, Inc. (NASDAQ:ASTH) saw a large decrease in short interest during the month of October. As of October 31st, there was short interest totalling 1,900,000 shares, a decrease of 12.8% from the October 15th total of 2,180,000 shares. Currently, 5.2% of the company’s shares are short sold. Based on an average daily volume of 269,800 shares, the days-to-cover ratio is currently 7.0 days.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on ASTH shares. Robert W. Baird boosted their price target on Astrana Health from $67.00 to $86.00 and gave the company an “outperform” rating in a research note on Wednesday. KeyCorp initiated coverage on shares of Astrana Health in a research note on Friday, October 11th. They issued a “sector weight” rating for the company. BTIG Research raised their target price on Astrana Health from $60.00 to $70.00 and gave the company a “buy” rating in a research note on Thursday, October 3rd. Stifel Nicolaus upped their price target on Astrana Health from $48.00 to $60.00 and gave the stock a “buy” rating in a research note on Thursday, August 1st. Finally, TD Cowen initiated coverage on Astrana Health in a report on Monday, October 14th. They set a “buy” rating and a $66.00 price objective for the company. One equities research analyst has rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, Astrana Health currently has an average rating of “Buy” and a consensus price target of $65.17.

Hedge Funds Weigh In On Astrana Health

Several hedge funds have recently made changes to their positions in ASTH. Central Pacific Bank Trust Division bought a new position in Astrana Health in the 3rd quarter valued at $160,000. SG Americas Securities LLC bought a new position in Astrana Health in the 3rd quarter worth about $680,000. Granite Bay Wealth Management LLC purchased a new stake in shares of Astrana Health in the 3rd quarter valued at about $290,000. Handelsbanken Fonder AB bought a new stake in shares of Astrana Health during the 3rd quarter valued at about $492,000. Finally, GAMMA Investing LLC bought a new position in shares of Astrana Health in the third quarter worth approximately $34,000. 52.77% of the stock is currently owned by hedge funds and other institutional investors.

Astrana Health Stock Down 2.6 %

Astrana Health stock opened at $40.81 on Friday. Astrana Health has a fifty-two week low of $32.04 and a fifty-two week high of $63.20. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.84 and a current ratio of 1.91. The firm’s 50-day simple moving average is $55.04 and its 200 day simple moving average is $47.74. The stock has a market cap of $2.30 billion, a PE ratio of 31.39, a price-to-earnings-growth ratio of 1.96 and a beta of 1.24.

Astrana Health (NASDAQ:ASTH) last issued its quarterly earnings results on Thursday, November 7th. The company reported $0.33 EPS for the quarter, meeting analysts’ consensus estimates of $0.33. The company had revenue of $478.71 million during the quarter, compared to the consensus estimate of $462.01 million. Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. During the same period last year, the business posted $0.47 earnings per share. Research analysts predict that Astrana Health will post 1.16 EPS for the current fiscal year.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.